Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease

Research output: Contribution to journalArticle

Abstract

Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by fibroinflammatory tissue in the periaortic or periiliac retroperitoneum, where it frequently encases ureters. There is emerging evidence that a subset of this disease is part of a spectrum of multisystemic autoimmune diseases collectively referred to as “immunoglobulin G4 (IgG4)-related disease”. Methods: We retrospectively analyzed 27 idiopathic RPF patients and identified a subset as IgG4-related RPF, which we categorized according to recently published comprehensive diagnostic criteria. We compared clinical and laboratory characteristics and response to treatment between the two groups. Results: Of 27 total patients, 16 (59.3%) were diagnosed as having IgG4-related RPF, and these were predominantly male. They were also significantly older and more likely to have other organ involvement, hydronephrosis, and postrenal acute kidney injury (AKI) compared to those with idiopathic RPF. However, there was no difference in response rate to systemic steroid treatment. Conclusion: IgG4-related RPF accounts for a substantial portion of RPF cases previously identified as “idiopathic RPF” in Korea. Clinical and laboratory characteristics of IgG4-related RPF are similar to those of idiopathic RPF except for a striking male predominance, older age, and higher incidence of postrenal AKI in IgG4-related RPF. More comprehensive, prospective studies are needed to clearly distinguish IgG4-related RPF from idiopathic RPF based on clinical manifestation and to further assess treatment response and long-term prognosis.

Original languageEnglish
Pages (from-to)42-48
Number of pages7
JournalKidney Research and Clinical Practice
Volume38
Issue number1
DOIs
Publication statusPublished - 2019 Mar 1

Fingerprint

Retroperitoneal Fibrosis
Immunoglobulins
Acute Kidney Injury
Hydronephrosis
Ureter
Korea
Rare Diseases
Autoimmune Diseases

Keywords

  • Acute kidney injury
  • Immunoglobulin G4
  • Retroperitoneal fibrosis
  • Steroid treatment

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

@article{8a821f5f4ff84f21840a4257d54c9793,
title = "Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease",
abstract = "Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by fibroinflammatory tissue in the periaortic or periiliac retroperitoneum, where it frequently encases ureters. There is emerging evidence that a subset of this disease is part of a spectrum of multisystemic autoimmune diseases collectively referred to as “immunoglobulin G4 (IgG4)-related disease”. Methods: We retrospectively analyzed 27 idiopathic RPF patients and identified a subset as IgG4-related RPF, which we categorized according to recently published comprehensive diagnostic criteria. We compared clinical and laboratory characteristics and response to treatment between the two groups. Results: Of 27 total patients, 16 (59.3{\%}) were diagnosed as having IgG4-related RPF, and these were predominantly male. They were also significantly older and more likely to have other organ involvement, hydronephrosis, and postrenal acute kidney injury (AKI) compared to those with idiopathic RPF. However, there was no difference in response rate to systemic steroid treatment. Conclusion: IgG4-related RPF accounts for a substantial portion of RPF cases previously identified as “idiopathic RPF” in Korea. Clinical and laboratory characteristics of IgG4-related RPF are similar to those of idiopathic RPF except for a striking male predominance, older age, and higher incidence of postrenal AKI in IgG4-related RPF. More comprehensive, prospective studies are needed to clearly distinguish IgG4-related RPF from idiopathic RPF based on clinical manifestation and to further assess treatment response and long-term prognosis.",
keywords = "Acute kidney injury, Immunoglobulin G4, Retroperitoneal fibrosis, Steroid treatment",
author = "Choi, {Yoon Kyung} and Yang, {Ji Hyun} and Ahn, {Shin Young} and Ko, {Gang Jee} and Oh, {Se Won} and Myung-Gyu Kim and Cho, {Won Yong} and Jo, {Sang Kyung}",
year = "2019",
month = "3",
day = "1",
doi = "10.23876/j.krcp.18.0052",
language = "English",
volume = "38",
pages = "42--48",
journal = "Kidney Research and Clinical Practice",
issn = "2211-9132",
publisher = "Elsevier Korea",
number = "1",

}

TY - JOUR

T1 - Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease

AU - Choi, Yoon Kyung

AU - Yang, Ji Hyun

AU - Ahn, Shin Young

AU - Ko, Gang Jee

AU - Oh, Se Won

AU - Kim, Myung-Gyu

AU - Cho, Won Yong

AU - Jo, Sang Kyung

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by fibroinflammatory tissue in the periaortic or periiliac retroperitoneum, where it frequently encases ureters. There is emerging evidence that a subset of this disease is part of a spectrum of multisystemic autoimmune diseases collectively referred to as “immunoglobulin G4 (IgG4)-related disease”. Methods: We retrospectively analyzed 27 idiopathic RPF patients and identified a subset as IgG4-related RPF, which we categorized according to recently published comprehensive diagnostic criteria. We compared clinical and laboratory characteristics and response to treatment between the two groups. Results: Of 27 total patients, 16 (59.3%) were diagnosed as having IgG4-related RPF, and these were predominantly male. They were also significantly older and more likely to have other organ involvement, hydronephrosis, and postrenal acute kidney injury (AKI) compared to those with idiopathic RPF. However, there was no difference in response rate to systemic steroid treatment. Conclusion: IgG4-related RPF accounts for a substantial portion of RPF cases previously identified as “idiopathic RPF” in Korea. Clinical and laboratory characteristics of IgG4-related RPF are similar to those of idiopathic RPF except for a striking male predominance, older age, and higher incidence of postrenal AKI in IgG4-related RPF. More comprehensive, prospective studies are needed to clearly distinguish IgG4-related RPF from idiopathic RPF based on clinical manifestation and to further assess treatment response and long-term prognosis.

AB - Background: Retroperitoneal fibrosis (RPF) is a rare disease characterized by fibroinflammatory tissue in the periaortic or periiliac retroperitoneum, where it frequently encases ureters. There is emerging evidence that a subset of this disease is part of a spectrum of multisystemic autoimmune diseases collectively referred to as “immunoglobulin G4 (IgG4)-related disease”. Methods: We retrospectively analyzed 27 idiopathic RPF patients and identified a subset as IgG4-related RPF, which we categorized according to recently published comprehensive diagnostic criteria. We compared clinical and laboratory characteristics and response to treatment between the two groups. Results: Of 27 total patients, 16 (59.3%) were diagnosed as having IgG4-related RPF, and these were predominantly male. They were also significantly older and more likely to have other organ involvement, hydronephrosis, and postrenal acute kidney injury (AKI) compared to those with idiopathic RPF. However, there was no difference in response rate to systemic steroid treatment. Conclusion: IgG4-related RPF accounts for a substantial portion of RPF cases previously identified as “idiopathic RPF” in Korea. Clinical and laboratory characteristics of IgG4-related RPF are similar to those of idiopathic RPF except for a striking male predominance, older age, and higher incidence of postrenal AKI in IgG4-related RPF. More comprehensive, prospective studies are needed to clearly distinguish IgG4-related RPF from idiopathic RPF based on clinical manifestation and to further assess treatment response and long-term prognosis.

KW - Acute kidney injury

KW - Immunoglobulin G4

KW - Retroperitoneal fibrosis

KW - Steroid treatment

UR - http://www.scopus.com/inward/record.url?scp=85067239334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067239334&partnerID=8YFLogxK

U2 - 10.23876/j.krcp.18.0052

DO - 10.23876/j.krcp.18.0052

M3 - Article

VL - 38

SP - 42

EP - 48

JO - Kidney Research and Clinical Practice

JF - Kidney Research and Clinical Practice

SN - 2211-9132

IS - 1

ER -